Cargando…

CD8(+) T Cells in Leishmania Infections: Friends or Foes?

Host protection against several intracellular pathogens requires the induction of CD8(+) T cell responses. CD8(+) T cells are potent effector cells that can produce high amounts of pro-inflammatory cytokines and kill infected target cells efficiently. However, a protective role for CD8(+) T cells du...

Descripción completa

Detalles Bibliográficos
Autores principales: Stäger, Simona, Rafati, Sima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342007/
https://www.ncbi.nlm.nih.gov/pubmed/22566891
http://dx.doi.org/10.3389/fimmu.2012.00005
_version_ 1782231612211068928
author Stäger, Simona
Rafati, Sima
author_facet Stäger, Simona
Rafati, Sima
author_sort Stäger, Simona
collection PubMed
description Host protection against several intracellular pathogens requires the induction of CD8(+) T cell responses. CD8(+) T cells are potent effector cells that can produce high amounts of pro-inflammatory cytokines and kill infected target cells efficiently. However, a protective role for CD8(+) T cells during Leishmania infections is still controversial and largely depends on the infection model. In this review, we discuss the role of CD8(+) T cells during various types of Leishmania infections, following vaccination, and as potential immunotherapeutic targets.
format Online
Article
Text
id pubmed-3342007
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33420072012-05-07 CD8(+) T Cells in Leishmania Infections: Friends or Foes? Stäger, Simona Rafati, Sima Front Immunol Immunology Host protection against several intracellular pathogens requires the induction of CD8(+) T cell responses. CD8(+) T cells are potent effector cells that can produce high amounts of pro-inflammatory cytokines and kill infected target cells efficiently. However, a protective role for CD8(+) T cells during Leishmania infections is still controversial and largely depends on the infection model. In this review, we discuss the role of CD8(+) T cells during various types of Leishmania infections, following vaccination, and as potential immunotherapeutic targets. Frontiers Research Foundation 2012-01-24 /pmc/articles/PMC3342007/ /pubmed/22566891 http://dx.doi.org/10.3389/fimmu.2012.00005 Text en Copyright © 2012 Stäger and Rafati. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
spellingShingle Immunology
Stäger, Simona
Rafati, Sima
CD8(+) T Cells in Leishmania Infections: Friends or Foes?
title CD8(+) T Cells in Leishmania Infections: Friends or Foes?
title_full CD8(+) T Cells in Leishmania Infections: Friends or Foes?
title_fullStr CD8(+) T Cells in Leishmania Infections: Friends or Foes?
title_full_unstemmed CD8(+) T Cells in Leishmania Infections: Friends or Foes?
title_short CD8(+) T Cells in Leishmania Infections: Friends or Foes?
title_sort cd8(+) t cells in leishmania infections: friends or foes?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342007/
https://www.ncbi.nlm.nih.gov/pubmed/22566891
http://dx.doi.org/10.3389/fimmu.2012.00005
work_keys_str_mv AT stagersimona cd8tcellsinleishmaniainfectionsfriendsorfoes
AT rafatisima cd8tcellsinleishmaniainfectionsfriendsorfoes